Literature DB >> 33341301

Arterial thrombosis in antiphospholipid syndrome (APS): Clinical approach and treatment. A systematic review.

Chunyan Cheng1, Gang-Yi Cheng2, Gentian Denas1, Vittorio Pengo3.   

Abstract

Thrombotic Antiphospholipid Syndrome (APS) is a condition affecting young individuals in whom a thromboembolic event occurs in the presence of circulating antiphospholipid antibodies (aPL). An extensive body of literature has covered the most common clinical presentation of the syndrome, venous thromboembolism. Arterial thrombosis in APS, a lesser clinical expression, is less studied. This review will concentrate on the body of literature concerning pathogenesis, clinical presentation and management of arterial thrombosis in APS.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Arterial; Glycoprotein; Phospholipids; Syndrome; Thrombosis

Year:  2020        PMID: 33341301     DOI: 10.1016/j.blre.2020.100788

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  4 in total

1.  Risk Factors and Outcomes of Acute Myocardial Infarction in a Cohort of Antiphospholipid Syndrome.

Authors:  Yuzhou Gan; Yawei Zhao; Gongming Li; Hua Ye; Yunshan Zhou; Chang Hou; Lan Wang; Jianping Guo; Chun Li
Journal:  Front Cardiovasc Med       Date:  2022-07-05

2.  Neuroimaging features of antiphospholipid antibody-related stroke compared with atrial fibrillation-related stroke.

Authors:  Wookjin Yang; Dong-Wan Kang; Jeong-Min Kim; Keun-Hwa Jung; Seung-Hoon Lee
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

Review 3.  VWF, Platelets and the Antiphospholipid Syndrome.

Authors:  Shengshi Huang; Marisa Ninivaggi; Walid Chayoua; Bas de Laat
Journal:  Int J Mol Sci       Date:  2021-04-18       Impact factor: 5.923

4.  Sex Differences in Clinical Characteristics and Prognosis in Primary Thrombotic Antiphospholipid Syndrome.

Authors:  Yongfa Huang; Huazhen Liu; Wanting Qi; Le Du; Mengtao Li; Xiaofeng Zeng; Xiaoxiao Guo; Jiuliang Zhao; Shuyang Zhang
Journal:  Front Cardiovasc Med       Date:  2022-07-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.